Stryker (SYK) insider sale: 1,785 shares at $393.07 reported
Robert S. Fletcher, VP and Chief Legal Officer of Stryker Corporation (SYK), reported an insider sale on 08/20/2025.
Rhea-AI Filing Summary
Robert S. Fletcher, VP and Chief Legal Officer of Stryker Corporation (SYK), reported an insider sale on 08/20/2025. The Form 4 shows a disposition of 1,785 shares of Stryker common stock at a reported price of $393.07 per share. After the reported sale, Mr. Fletcher beneficially owned 10,457 shares directly and 162 shares indirectly through a 401(k) account. The filing was signed on 08/21/2025 by an attorney-in-fact for Mr. Fletcher. The form indicates this was an individual filing by one reporting person and does not list any derivative transactions.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine officer sale of shares; ownership remains concentrated at modest levels, filing shows compliance with Section 16 reporting.
The reported sale of 1,785 shares at $393.07 appears as a straightforward Section 16 disclosure by an officer who also serves as a director. The remaining direct ownership of 10,457 shares and an indirect holding of 162 shares via a 401(k) are explicitly stated. There are no derivative positions disclosed and no indication of an amendment or reliance on a trading plan in the filing. The form is signed by an attorney-in-fact, which is common for administrative filings. From a governance perspective, the filing documents compliance with insider trading reporting requirements but does not, by itself, indicate a change in control or governance posture.
TL;DR Single-date disposition by an insider; transaction size is small relative to typical institutional holdings and presents limited market impact.
The sale on 08/20/2025 of 1,785 shares at $393.07 reduces the reporting person's direct stake to 10,457 shares. The filing lists no option exercise, no acquisitions, and no derivative activity. Given the absolute share counts disclosed, the transaction is a modest insider sale and likely not material to the company’s capitalization. This Form 4 furnishes required transparency on insider activity but contains no additional financial metrics or indications of company performance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,785 | $393.07 | $702K |
| holding | Common Stock | -- | -- | -- |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Robert S. Fletcher (SYK) report on 08/20/2025?
What is Robert S. Fletcher’s role at Stryker as listed on the Form 4?
Are there any derivative transactions or option exercises disclosed in this Form 4?
Who signed the Form 4 and when was it signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.